English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 907429 Online Users : 960
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
感染症與疫苗研究所
冷治湘
--期刊論文
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
感染症與疫苗研究所
>
冷治湘
>
期刊論文
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Loading...
Siblings
圖書
[
1
/1]
會議論文/會議摘要
[
4
/5]
專利
[
0
/27]
Collection Statistics
近3年內發表的文件:2(3.57%)
含全文筆數:56(100.00%)
文件下載次數統計
下載大於0次:56(100.00%)
下載大於100次:54(96.43%)
檔案下載總次數:36536(91.70%)
最後更新時間: 2024-12-01 05:36
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
SARS-CoV-2 spike-FLIPr fusion prote...
A broad-spectrum pneumococcal vacci...
Truncated pneumolysin from streptoc...
Domain 4 of pneumolysin from Strept...
Delivery of antigen to CD8(+) dendr...
A therapeutic vaccine targeting HPV...
Polysorbasome: A colloidal vesicle ...
Efficient uptake of recombinant lip...
Identification of immunoreactive pe...
Degradable emulsion as vaccine adju...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 26-50 of 56. (3 Page(s) Totally)
<<
<
1
2
3
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2014-03-19
Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy
Molecular Cancer. 2014 Mar 19;13:Article number 60.
2014-03
Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity
Vaccine. 2014 Mar;32(12):1346-1353.
2014-03
A purified recombinant lipopeptide as adjuvant for cancer immunotherapy
BioMed Research International. 2014 Mar;2014:Article number 349783.
2014-01
A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity
Journal of Controlled Release. 2014 Jan;173(1):158-165.
2014-01
Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide
Biomaterials. 2014 Jan;35(5):1686-1695.
2013-09-19
Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement
PLoS Neglected Tropical Diseases. 2013 Sep 19;7(9):Article number e2432.
2013-09
Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III
Microbes and Infection. 2013 Sep;15(10-11):719-728.
2013-07
A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates
Archives of Virology. 2013 Jul;158(7):1523-1531.
2012-07
Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model
PLoS ONE. 2012 Jul;7(7):Article number e40970.
2012-05
Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses
PLoS Neglected Tropical Diseases. 2012 May;6(5):Article number e1645.
2012-02
Influence of medium components on the expression of recombinant lipoproteins in Escherichia coli
Applied Microbiology and Biotechnology. 2012 Feb;93(4):1539-1552.
2011-08
Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosis-independent pathway in vivo
Journal of Leukocyte Biology. 2011 Aug;90(2):323-332.
2011-08
A novel single-dose dengue subunit vaccine induces memory immune responses
PLoS ONE. 2011 Aug;6(8):Article number e23319.
2011-07
Rapid Isolation and characterization of bacterial lipopeptides using liquid chromatography and mass spectrometry analysis
Proteomics. 2011 Jul;11(13):2620-2627.
2010-11
Biochemical characterizations of Escherichia coli-expressed protective antigen Ag473 of Neisseria meningitides group B
Vaccine. 2010 Nov;28(51):8175-8182.
2010-11
Generating stable chinese hamster ovary cell clones to produce a truncated SARS-CoV spike protein for vaccine development
Biotechnology Progress. 2010 Nov;26(6):1733-1740.
2010-09
Enhancement of specific cell-capture efficiency using a reversible dielectrophoresis field
Sensors and Actuators, A: Physical. 2010 Sep;163(1):128-137
2010-08
Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice
PLoS ONE. 2010 Aug;5(8):Article number e12279.
2010-07
A recombinant lipoprotein containing an unsaturated fatty acid activates NF-kappaB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide
Molecular Immunology. 2010 Jul;47(11-12):2015-2021.
2009-11-01
Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization
Cancer Biology and Therapy. 2009 Nov 1;8(21):2025-2032.
2009-09-04
Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses
Vaccine. 2009 Sep 4;27(40):5460-5471.
2009-08
Formulation and immunological evaluation of novel vaccine delivery systems based on bioresorbable poly(ethylene glycol)-block-poly(lactide-co-epsilon-caprolactone)
Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2009 Aug;90(2):832-841.
2009-08
Development of multi-phase emulsions based on bioresorbable polymers and oily adjuvant
Pharmaceutical Research. 2009 Aug;26(8):1856-1862.
2009-05-22
Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus
Biochemical and Biophysical Research Communications. 2009 May 22;383(1):27-31.
2009-05
Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine
Microbes and Infection. 2009 May;11(6-7):654-660.
Showing items 26-50 of 56. (3 Page(s) Totally)
<<
<
1
2
3
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback